Quest Diagnostics Inc (DGX)

$183.46 +3.32 (1.84%)
Market Cap 20.14B
Revenue (ttm) 9.87B
Net Income (ttm) 871.00M
EPS (ttm) N/A
PE Ratio 19.52
Forward PE 18.76
Profit Margin 8.82%
Debt to Equity Ratio 0.78
Volume 598,500
Avg Vol 1,024,370
Day's Range N/A - N/A
Shares Out 111.82M
Stochastic %K 90%
Beta 0.54
Analysts Sell
Price Target $188.71

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 973 520 2700
Address:
500 Plaza Drive, Secaucus, United States
StockAutoPro
StockAutoPro Sep. 5 at 7:11 PM
$DGX: Buy target $180.2 Sell target $191.31 Rising health awareness may boost demand for diagnostic services, providing growth opportunity for leading lab chains.
0 · Reply
StockAutoPro
StockAutoPro Sep. 4 at 3:02 PM
$DGX: Buy target $178.54 Sell target $189.57 Consider investing in the DGX sector due to increased demand for diagnostic testing services.
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 3:32 AM
$DGX: Buy target $176.7 Sell target $187.63 Strong earnings report indicates potential growth for this leading diagnostic services provider.
0 · Reply
StockAutoPro
StockAutoPro Aug. 31 at 4:41 AM
$DGX: Buy target $179.64 Sell target $190.72 Strong demand for diagnostic services propels growth in this leading medical laboratory stock.
0 · Reply
StockAutoPro
StockAutoPro Aug. 29 at 4:46 PM
$DGX: Buy target $179.64 Sell target $190.72 Strong growth potential observed in leading clinical laboratory services provider amid increasing demand for diagnostic testing.
0 · Reply
ChristinaC
ChristinaC Aug. 28 at 2:18 PM
$TCOM Oh yeah baby! Patience pays off. Let's go $CMG, $PANW $NU $DGX
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 1:42 PM
$DGX partners with Corewell Health — what's the impact on its growth strategy? 🚀 Quest Diagnostics is expanding with a JV aimed at boosting lab service access in Michigan, leveraging advanced tech and strategic collaborations. This aligns with DGX's goal to tap into growth areas and could sustain positive market sentiment. Explore the full story here 👉 https://www.zacks.com/stock/news/2743996/dgx-stock-gains-following-a-new-joint-venture-with-corewell-health?cid=sm-stocktwits-2-2743996-body-9942&ADID=SYND_STOCKTWITS_TWEET_2_2743996_BODY_9942
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 12:42 PM
$DGX pops on new growth catalyst 🚀 Shares are climbing after a joint venture with Corewell Health to expand advanced lab services across Michigan — a strategic move boosting reach and scale. Full breakdown here 👉 https://www.zacks.com/stock/news/2743996/dgx-stock-gains-following-a-new-joint-venture-with-corewell-health?cid=sm-stocktwits-2-2743996-teaser-9941&ADID=SYND_STOCKTWITS_TWEET_2_2743996_TEASER_9941
0 · Reply
Small_time_trader
Small_time_trader Aug. 27 at 2:10 PM
$DGX FYI Mega Lab to be built in MI. Lots of good ‘sticky’ lab work for DGX. https://www.investing.com/news/company-news/corewell-health-quest-diagnostics-form-lab-services-joint-venture-93CH-4210997
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 25 at 12:56 PM
$DGX Quest Diagnostics' Haystack MRD Test Granted FDA Breakthrough Device Designation For Stage II Colorectal Cancer
0 · Reply
Latest News on DGX
Quest Diagnostics Incorporated (DGX) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 10, 2025, 1:16 PM EDT - 1 day ago

Quest Diagnostics Incorporated (DGX) Presents At Baird Global Healthcare Conference 2025 Transcript

Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering

Sep 4, 2025, 9:32 AM EDT - 8 days ago

Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering

Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index

Sep 2, 2025, 6:27 AM EDT - 10 days ago

Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index

Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan

Aug 26, 2025, 9:00 AM EDT - 17 days ago

Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

Aug 25, 2025, 8:52 AM EDT - 18 days ago

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

Aug 15, 2025, 6:14 PM EDT - 27 days ago

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

Quest Diagnostics Declares Quarterly Cash Dividend

Aug 13, 2025, 6:35 PM EDT - 4 weeks ago

Quest Diagnostics Declares Quarterly Cash Dividend

Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

Aug 7, 2025, 9:08 AM EDT - 5 weeks ago

Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care

Aug 5, 2025, 8:33 AM EDT - 5 weeks ago

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

Jul 29, 2025, 8:52 AM EDT - 6 weeks ago

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

PACB

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Jul 22, 2025, 1:10 PM EDT - 7 weeks ago

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 12:22 PM EDT - 7 weeks ago

Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

Jul 22, 2025, 7:17 AM EDT - 7 weeks ago

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Jul 22, 2025, 6:47 AM EDT - 7 weeks ago

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:57 AM EDT - 2 months ago

Quest Diagnostics Introduces Testing for Oropouche Virus

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Jul 15, 2025, 7:36 AM EDT - 2 months ago

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Jul 9, 2025, 8:24 AM EDT - 2 months ago

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 25, 2025, 9:07 AM EDT - 2 months ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

Jun 23, 2025, 10:52 AM EDT - 2 months ago

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

Jun 10, 2025, 8:03 AM EDT - 3 months ago

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

May 20, 2025, 8:52 AM EDT - 4 months ago

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

May 16, 2025, 1:11 PM EDT - 4 months ago

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

May 13, 2025, 6:03 AM EDT - 4 months ago

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

Quest Diagnostics: A Leader But Waiting For Better Price

May 3, 2025, 4:26 AM EDT - 4 months ago

Quest Diagnostics: A Leader But Waiting For Better Price

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Apr 23, 2025, 1:17 PM EDT - 5 months ago

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Apr 22, 2025, 12:09 PM EDT - 5 months ago

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Apr 22, 2025, 11:39 AM EDT - 5 months ago

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Quest beats quarterly profit estimates on strong demand for diagnostic tests

Apr 22, 2025, 7:37 AM EDT - 5 months ago

Quest beats quarterly profit estimates on strong demand for diagnostic tests

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

Apr 22, 2025, 7:01 AM EDT - 5 months ago

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

Apr 22, 2025, 6:43 AM EDT - 5 months ago

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

Apr 9, 2025, 7:53 AM EDT - 5 months ago

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

8 Upcoming Dividend Increases During Volatile Times

Apr 4, 2025, 1:43 PM EDT - 5 months ago

8 Upcoming Dividend Increases During Volatile Times

AMT BKU GD KAI ORCL REIT RNP

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Apr 2, 2025, 7:06 AM EDT - 5 months ago

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

Apr 1, 2025, 4:23 PM EDT - 5 months ago

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Mar 19, 2025, 7:52 AM EDT - 6 months ago

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI

Mar 18, 2025, 9:00 AM EDT - 6 months ago

Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Feb 24, 2025, 8:00 AM EST - 7 months ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

FMS

Quest Diagnostics to Host Investor Day on March 19, 2025

Feb 13, 2025, 4:54 PM EST - 7 months ago

Quest Diagnostics to Host Investor Day on March 19, 2025

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

Feb 12, 2025, 9:00 AM EST - 7 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAL

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Jan 30, 2025, 4:14 PM EST - 8 months ago

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 2:35 PM EST - 8 months ago

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Jan 30, 2025, 6:45 AM EST - 8 months ago

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Jan 27, 2025, 8:56 AM EST - 8 months ago

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Jan 8, 2025, 8:42 AM EST - 8 months ago

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Jan 2, 2025, 11:00 AM EST - 9 months ago

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference

Dec 3, 2024, 9:50 AM EST - 10 months ago

Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference

Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health

Dec 3, 2024, 8:23 AM EST - 10 months ago

Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health

15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season

Nov 25, 2024, 10:44 AM EST - 10 months ago

15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season

NVDA PLTR APH ATO BLK CNC CTRA

Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

Nov 15, 2024, 1:05 PM EST - 10 months ago

Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base

Oct 24, 2024, 10:10 AM EDT - 11 months ago

Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base

StockAutoPro
StockAutoPro Sep. 5 at 7:11 PM
$DGX: Buy target $180.2 Sell target $191.31 Rising health awareness may boost demand for diagnostic services, providing growth opportunity for leading lab chains.
0 · Reply
StockAutoPro
StockAutoPro Sep. 4 at 3:02 PM
$DGX: Buy target $178.54 Sell target $189.57 Consider investing in the DGX sector due to increased demand for diagnostic testing services.
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 3:32 AM
$DGX: Buy target $176.7 Sell target $187.63 Strong earnings report indicates potential growth for this leading diagnostic services provider.
0 · Reply
StockAutoPro
StockAutoPro Aug. 31 at 4:41 AM
$DGX: Buy target $179.64 Sell target $190.72 Strong demand for diagnostic services propels growth in this leading medical laboratory stock.
0 · Reply
StockAutoPro
StockAutoPro Aug. 29 at 4:46 PM
$DGX: Buy target $179.64 Sell target $190.72 Strong growth potential observed in leading clinical laboratory services provider amid increasing demand for diagnostic testing.
0 · Reply
ChristinaC
ChristinaC Aug. 28 at 2:18 PM
$TCOM Oh yeah baby! Patience pays off. Let's go $CMG, $PANW $NU $DGX
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 1:42 PM
$DGX partners with Corewell Health — what's the impact on its growth strategy? 🚀 Quest Diagnostics is expanding with a JV aimed at boosting lab service access in Michigan, leveraging advanced tech and strategic collaborations. This aligns with DGX's goal to tap into growth areas and could sustain positive market sentiment. Explore the full story here 👉 https://www.zacks.com/stock/news/2743996/dgx-stock-gains-following-a-new-joint-venture-with-corewell-health?cid=sm-stocktwits-2-2743996-body-9942&ADID=SYND_STOCKTWITS_TWEET_2_2743996_BODY_9942
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 12:42 PM
$DGX pops on new growth catalyst 🚀 Shares are climbing after a joint venture with Corewell Health to expand advanced lab services across Michigan — a strategic move boosting reach and scale. Full breakdown here 👉 https://www.zacks.com/stock/news/2743996/dgx-stock-gains-following-a-new-joint-venture-with-corewell-health?cid=sm-stocktwits-2-2743996-teaser-9941&ADID=SYND_STOCKTWITS_TWEET_2_2743996_TEASER_9941
0 · Reply
Small_time_trader
Small_time_trader Aug. 27 at 2:10 PM
$DGX FYI Mega Lab to be built in MI. Lots of good ‘sticky’ lab work for DGX. https://www.investing.com/news/company-news/corewell-health-quest-diagnostics-form-lab-services-joint-venture-93CH-4210997
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 25 at 12:56 PM
$DGX Quest Diagnostics' Haystack MRD Test Granted FDA Breakthrough Device Designation For Stage II Colorectal Cancer
0 · Reply
ChristinaC
ChristinaC Aug. 25 at 12:45 PM
$DGX normal pullback due to insider offloading the stock. This is so undervalued, if it pulls back near $160ISH i will load up some more for long term hold.
0 · Reply
DiamondSecurities
DiamondSecurities Aug. 23 at 10:59 AM
$DGX Quest Diagnostics Incorporated is facing lab testing demand normalization and competitive pressure
0 · Reply
Small_time_trader
Small_time_trader Aug. 21 at 7:04 PM
$DGX Quest to parter with Mass Gen Hospital If Haystack starts to take off - look out https://clpmag.com/disease-states/cancer/mass-general-brigham-launches-clinical-trials-haystack-mrd-ctdna-testing/
0 · Reply
ZacksResearch
ZacksResearch Aug. 21 at 2:29 PM
$DGX up 20.6% in a year — is it still a buy? 🚀 Quest Diagnostics is driving growth through strategic acquisitions and double-digit revenue gains in areas like advanced cardiometabolic in the second quarter of 2025. Plus, its disciplined cost management enhances appeal. But rising debt and macroeconomic uncertainties loom large. Discover the full investment case here 👉 https://www.zacks.com/stock/news/2740891/should-quest-diagnostics-stock-be-in-your-portfolio-right-now?cid=sm-stocktwits-2-2740891-body-8802&ADID=SYND_STOCKTWITS_TWEET_2_2740891_BODY_8802
0 · Reply
ZacksResearch
ZacksResearch Aug. 21 at 1:29 PM
$DGX — buy, sell, or avoid? 🧪 The stock has been put under the microscope with a fresh look at whether Quest Diagnostics deserves a spot in your portfolio right now. Full breakdown here 👉 https://www.zacks.com/stock/news/2740891/should-quest-diagnostics-stock-be-in-your-portfolio-right-now?cid=sm-stocktwits-2-2740891-teaser-8783&ADID=SYND_STOCKTWITS_TWEET_2_2740891_TEASER_8783
0 · Reply
Small_time_trader
Small_time_trader Aug. 20 at 3:27 AM
$DGX
0 · Reply
Small_time_trader
Small_time_trader Aug. 15 at 4:05 PM
$DGX Getting comfy in the 170s Is today the day for 180 ?
0 · Reply
StockAutoPro
StockAutoPro Aug. 14 at 3:48 PM
$DGX: Buy target $175.78 Sell target $186.67 Strong diagnostics demand predicts robust growth for this leading healthcare diagnostic company.
0 · Reply
StockAutoPro
StockAutoPro Aug. 11 at 4:57 PM
$DGX: Buy target $175.45 Sell target $186.32 Rising demand for telehealth services could boost the performance of this leading digital health platform.
0 · Reply
andftbl
andftbl Aug. 1 at 4:28 PM
$DGX Back up?
0 · Reply
patten1962
patten1962 Jul. 30 at 12:28 PM
$DGX https://newsroom.questdiagnostics.com/2025-07-29-Athena-Diagnostics-Improves-Ataxia-Movement-Disorder-Testing-with-Novel-Long-Read-Gene-Sequencing?s=09 $PACB
0 · Reply
patten1962
patten1962 Jul. 30 at 12:27 PM
$PACB Today is a great example of this Stocktwits $PACB forum. 14k followers. Maybe I wrong but I think $DGX News with PacBio is pretty positive. Very few reactions. Find it odd.
0 · Reply